Abstract:Extracellular micro- and nanoscale membrane vesicles produced by different cells progressively attract the attention of the scientific community. They function as mediators of intercellular communication and transport genetic material and signaling molecules between the cells. In the context of keeping homeostasis, the extracellular vesicles contribute to the regulation of various systemic and local processes. Vesicles released by the tumor and activated stromal cells exhibit multiple functions including support of tumor growth, preparation of the pre-metastatic niches, and immune suppression. Considerable progress has been made regarding the criteria of classification of the vesicles according to their origin, content, and function: Exosomes, microvesicles, also referred to as microparticles or ectosomes, and large oncosomes were defined as actively released vesicles. Additionally, apoptotic bodies represented by a highly heterogeneous population of particles produced during apoptosis, the programmed cell death, should be considered. Because the majority of isolation techniques do not allow the separation of different types of vesicles, a joined term "extracellular vesicles" (EVs) was recommended by the ISEV community for the definition of vesicles isolated from either the cell culture supernatants or the body fluids. Because EV content reflects the content of the cell of origin, multiple studies on EVs from body fluids in the context of cancer diagnosis, prediction, and prognosis were performed, actively supporting their high potential as a biomarker source. Here, we review the leading achievements in EV analysis from body fluids, defined as EV-based liquid biopsy, and provide an overview of the main EV constituents: EV surface proteins, intravesicular soluble proteins, EV RNA including mRNA and miRNA, and EV DNA as potential biomarkers. Furthermore, we discuss recent developments in technology for quantitative EV analysis in the clinical setting and future perspectives toward miniaturized high-precision liquid biopsy approaches.

Multi-omics analysis revealed the role of extracellular vesicles in hepatobiliary & pancreatic tumor

Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles

Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers

Diagnostic potential of exosomal extracellular vesicles in oncology

Recent Progress in Isolation and Detection of Extracellular Vesicles for Cancer Diagnostics

Extracellular Vesicles: Recent Developments in Technology and Perspectives for Cancer Liquid Biopsy

Extracellular Vesicles (evs) in Tumor Diagnosis and Therapy

Multi-omics analysis identified extracellular vesicles as biomarkers for cardiovascular diseases

Clinical value and prospect of extracellular vesicle miRNAs as novel liquid biopsy molecular biomarkers of tumor

Isolation and Detection Technologies of Extracellular Vesicles and Application on Cancer Diagnostic

Extracellular Vesicles heterogeneity through the lens of multiomics

Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy

Recent advances to address challenges in extracellular vesicle-based applications for lung cancer

Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer

Harnessing microRNA-enriched extracellular vesicles for liquid biopsy

From biogenesis to aptasensors: advancements in analysis for tumor-derived extracellular vesicles research

Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine

Exosomes as a new frontier of cancer liquid biopsy

Harnessing extracellular vesicles using liquid biopsy for cancer diagnosis and monitoring: highlights from AACR Annual Meeting 2024

Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine